The Board of Directors of ASIT Biotech S.A. appointed Yves Désiront as interim CFO, while the company is looking for a new profile to replace Everard van der Straten, who supervised the financial organization of the company and its financing since its IPO in 2016. Everard van der Straten remains a Board member. Philippe Degeer to join the Board of Directors as representative of Meusinvest.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0236 EUR | -.--% | +7.27% | +0.43% |
2023 | DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
+0.43% | 38.12M | |
-24.16% | 7.76B | |
+68.65% | 4.33B | |
-2.98% | 2.64B | |
+2.72% | 2.63B | |
-46.17% | 2.16B | |
-22.12% | 1.46B | |
+13.62% | 1.17B | |
-43.81% | 1.14B | |
+20.41% | 999M |
- Stock Market
- Equities
- DMSIM Stock
- News DMS Imaging
- ASIT Biotech S.A. Announces Executive Changes